查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1662938

循環性腫瘤細胞全球市場報告 2025

Circulating Tumor Cells Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

循環性腫瘤細胞市場規模預計在未來幾年將快速成長。到 2029 年，這一數字將成長至 216.8 億美元，複合年成長率為 12.8%。預測期內的成長可歸因照護現場CTC 檢測、微射流的採用、對罕見癌症類型的關注、CTC 檢測的標準化、基於 CTC 的臨床試驗的擴展、經濟成長以及新興市場的成長。預測期內的關鍵趨勢包括 CTC 分離技術的創新、政府對 CTC 研究的資助、CTC 檢測技術的進步、用於癌症監測的液態切片、與單細胞分析的整合以及與人工智慧 (AI) 的技術融合。

預計未來幾年癌症發生率的增加將推動循環性腫瘤細胞市場的成長。癌症是一種以某些身體細胞不受控制地生長為特徵的疾病，這些細胞可以轉移到其他部位。循環性腫瘤細胞用於癌症的早期發現和診斷，因此癌症患者數量的增加促進了循環性腫瘤細胞市場的擴大。例如，自願組織《美國癌症美國》預測，2023年1月，美國將有1,958,310例癌症新病例，609,820例癌症相關死亡病例。因此，癌症發生率的增加正在推動循環性腫瘤細胞市場的成長。

臨床試驗中擴大採用循環性腫瘤細胞分析也可能是市場成長的主要驅動力。臨床試驗對於評估新治療方法的安全性和有效性至關重要，它受益於循環性腫瘤細胞(CTC) 分析的整合。這種整合將增強我們評估治療反應的能力，實現更早的檢測和監測，根據特定患者情況量身定做干涉措施，並全面提高臨床終點的效率和檢驗。截至 2023 年 5 月，ClinicalTrials.gov 報告稱，已註冊 452,604 項臨床試驗，其中 64,838 項正在積極尋找參與者。臨床試驗數量較 2021 年註冊的 365,000 項試驗增加，支持了循環性腫瘤細胞分析在研究中的日益普及。因此，CTC分析在臨床試驗中的日益整合是推動循環性腫瘤細胞市場發展的主要因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球循環性腫瘤細胞PESTEL分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球循環性腫瘤細胞市場：成長率分析
  • 全球循環性腫瘤細胞市場表現：規模與成長，2019 年至 2024 年
  • 全球循環性腫瘤細胞市場預測：2024-2029 年及 2034 年規模與成長
  • 全球循環性腫瘤細胞總目標市場 (TAM)

第6章 市場細分

  • 全球循環性腫瘤細胞市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 套件和試劑
  • 採血管
  • 設備或系統
  • 全球循環性腫瘤細胞市場（按技術、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • CTC 富集
  • CTC檢測
  • CTC分析
  • 全球循環性腫瘤細胞市場（依樣本、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 血
  • 骨髓
  • 其他體液
  • 全球循環性腫瘤細胞市場（按應用、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 臨床或液態生物檢體
  • 調查
  • 全球循環性腫瘤細胞市場，按套件和試劑類型細分，性能和預測，2019-2024 年，2024-2029 年，2034 年
  • 細胞富集試劑套件
  • 檢測試劑套件
  • 核酸分離試劑套件
  • 全球循環性腫瘤細胞市場，依採血管類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 標準採血管
  • 特殊採血管
  • 全球循環性腫瘤細胞市場，按設備或系統類型細分，性能和預測，2019-2024 年，2024-2029 年，2034 年
  • 微流體設備
  • 自動細胞捕獲系統
  • 影像系統

第7章 區域和國家分析

  • 全球循環性腫瘤細胞市場：按地區、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球循環性腫瘤細胞市場：按國家、表現和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 循環性腫瘤細胞市場：競爭格局
  • 循環性腫瘤細胞市場：公司簡介
    • Precision Medicine Group LLC Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Ikonisys Inc.
  • Qiagen NV
  • ScreenCell SAS
  • STEMCELL Technologies Inc.
  • Sysmex Corporation
  • Aviva Biosciences Corporation
  • LungLife AI Inc.
  • Miltenyi Biotec GmbH
  • Menarini Silicon Biosystems SpA
  • Canopus Bioscience Ltd.
  • IVDiagnostics Inc.
  • BioFluidica Inc.
  • Biolidics Limited
  • Rarecells Diagnostics SAS
  • LineaRx Inc.

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 循環性腫瘤細胞市場 2029：提供新機會的國家
  • 循環性腫瘤細胞市場 2029：提供新機會的細分市場
  • 循環性腫瘤細胞市場 2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r23254

Circulating tumor cells (CTCs) represent solid tumor-derived cells that have detached from the primary tumor and entered the bloodstream, providing valuable diagnostic and prognostic information for cancer.

The primary products related to circulating tumor cells encompass kits and reagents, along with blood collection tubes and devices or systems. Kits and reagents constitute a comprehensive set of consumables comprising elements such as a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. These products are utilized for collecting various specimens from the human body, including blood, bone marrow, and other bodily fluids. They leverage different technologies such as CTC enrichment, detection, and analysis, facilitating applications in clinical or liquid biopsy procedures, as well as in research endeavors.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $11.9 billion in 2024 to $13.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection.

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $21.68 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to point-of-care CTC testing, adoption of microfluidics, focus on rare cancer types, standardization of CTC assays, expansion of CTC-based clinical trials, economic and emerging market growth. Major trends in the forecast period include innovations in CTC isolation techniques, government funding for CTC research, advancements in CTC detection technologies, liquid biopsy for cancer monitoring, integration with single-cell analysis, technological convergence with artificial intelligence (AI).

The increasing incidence of cancer is expected to drive the growth of the circulating tumor cells market in the future. Cancer is a disease characterized by the uncontrolled growth of certain body cells, which can spread to other areas. Circulating tumor cells are utilized for the early detection and diagnosis of cancer, thereby contributing to the expansion of the circulating tumor cells market as cancer cases rise. For example, in January 2023, the American Cancer Society Journals, a US-based voluntary health organization, projected that 1,958,310 new cancer cases would be diagnosed in the United States, with 609,820 expected cancer-related deaths. Thus, the rising incidence of cancer is fueling the growth of the circulating tumor cells market.

The increasing adoption of circulating tumor cells analysis in clinical trials is poised to be a significant driver for the market's growth. Clinical trials, essential for assessing the safety and efficacy of new medical treatments, benefit from the integration of circulating tumor cells (CTC) analysis. This integration enhances the ability to evaluate treatment response, enable early detection and monitoring, tailor interventions to specific patient profiles, and overall, improve the efficiency and validation of clinical endpoints. As of May 2023, ClinicalTrials.gov reported 452,604 registered clinical studies, with 64,838 actively seeking participants. This surge in clinical trials, up from 365,000 registered trials in 2021, underscores the increasing adoption of circulating tumor cells analysis in research. Consequently, the growing integration of CTC analysis in clinical trials is a key driver propelling the circulating tumor cells market.

Product innovations are a significant trend gaining traction in the circulating tumor cells market. Major companies in this sector are concentrating on developing innovative products to bolster their market position. For example, in June 2024, Bio-Rad Laboratories, Inc., a US-based medical laboratory, introduced the Celselect Slides 2.0. This product is designed to improve the capture of rare cells and circulating tumor cells (CTCs), thereby enhancing the accuracy and efficiency of cell analysis for both clinical and research applications.

Major players in the circulating tumor cells market are strategically focusing on the development of innovative products, particularly in the domain of oncology liquid biopsy, to drive revenue growth. Oncology liquid biopsy involves a minimally invasive or non-invasive technique for detecting and monitoring disease biomarkers present in bodily fluids such as blood, urine, and sputum. A case in point is BillionToOne Inc., a prominent US-based biotech company specializing in molecular diagnostics. In June 2022, the company introduced oncology liquid biopsy products, namely NorthStar Select and NorthStar Response. NorthStar Select is a comprehensive somatic mutation profiling panel designed for cancer, utilizing BillionToOne's unique molecular counting method, Quantitative Counting Templates (QCTs), to identify actionable mutations with a notable limit of detection. On the other hand, NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test, providing precise estimates of circulating tumor DNA (ctDNA) methylation burden through molecular counting technologies.

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition is intended to strengthen Cell Microsystems' capabilities in cell analysis and offer advanced solutions for both research and clinical applications. Fluxion Biosciences, also based in the US, specializes in technologies for isolating and analyzing circulating tumor cells (CTCs).

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Circulating Tumor Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on circulating tumor cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for circulating tumor cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The circulating tumor cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Blood Collection Tubes; Devices Or Systems
  • 2) By Technology: CTC Enrichment; CTC Detection; CTC Analysis
  • 3) By Specimen: Blood; Bone Marrow; Other Body Fluids
  • 4) By Application: Clinical Or Liquid Biopsy; Research
  • Subsegments:
  • 1) By Kits And Reagents: Cell Enrichment Kits; Detection Kits; Nucleic Acid Isolation Kits
  • 2) By Blood Collection Tubes: Standard Blood Collection Tubes; Specialized Blood Collection Tubes
  • 3) By Devices Or Systems: Microfluidic Devices; Automated Cell Capture Systems; Imaging Systems
  • Companies Mentioned: Precision Medicine Group LLC; Bio-Techne Corporation; BIOCEPT Inc.; Creativ MicroTech Inc.; Fluxion Biosciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Circulating Tumor Cells Market Characteristics

3. Circulating Tumor Cells Market Trends And Strategies

4. Circulating Tumor Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Circulating Tumor Cells Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Circulating Tumor Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Circulating Tumor Cells Market Growth Rate Analysis
  • 5.4. Global Circulating Tumor Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Circulating Tumor Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Circulating Tumor Cells Total Addressable Market (TAM)

6. Circulating Tumor Cells Market Segmentation

  • 6.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Reagents
  • Blood Collection Tubes
  • Devices Or Systems
  • 6.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CTC Enrichment
  • CTC Detection
  • CTC Analysis
  • 6.3. Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Bone Marrow
  • Other Body Fluids
  • 6.4. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Or Liquid Biopsy
  • Research
  • 6.5. Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Enrichment Kits
  • Detection Kits
  • Nucleic Acid Isolation Kits
  • 6.6. Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Blood Collection Tubes
  • Specialized Blood Collection Tubes
  • 6.7. Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microfluidic Devices
  • Automated Cell Capture Systems
  • Imaging Systems

7. Circulating Tumor Cells Market Regional And Country Analysis

  • 7.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Circulating Tumor Cells Market

  • 8.1. Asia-Pacific Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Circulating Tumor Cells Market

  • 9.1. China Circulating Tumor Cells Market Overview
  • 9.2. China Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Circulating Tumor Cells Market

  • 10.1. India Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Circulating Tumor Cells Market

  • 11.1. Japan Circulating Tumor Cells Market Overview
  • 11.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Circulating Tumor Cells Market

  • 12.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Circulating Tumor Cells Market

  • 13.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Circulating Tumor Cells Market

  • 14.1. South Korea Circulating Tumor Cells Market Overview
  • 14.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Circulating Tumor Cells Market

  • 15.1. Western Europe Circulating Tumor Cells Market Overview
  • 15.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Circulating Tumor Cells Market

  • 16.1. UK Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Circulating Tumor Cells Market

  • 17.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Circulating Tumor Cells Market

  • 18.1. France Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Circulating Tumor Cells Market

  • 19.1. Italy Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Circulating Tumor Cells Market

  • 20.1. Spain Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Circulating Tumor Cells Market

  • 21.1. Eastern Europe Circulating Tumor Cells Market Overview
  • 21.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Circulating Tumor Cells Market

  • 22.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Circulating Tumor Cells Market

  • 23.1. North America Circulating Tumor Cells Market Overview
  • 23.2. North America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Circulating Tumor Cells Market

  • 24.1. USA Circulating Tumor Cells Market Overview
  • 24.2. USA Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Circulating Tumor Cells Market

  • 25.1. Canada Circulating Tumor Cells Market Overview
  • 25.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Circulating Tumor Cells Market

  • 26.1. South America Circulating Tumor Cells Market Overview
  • 26.2. South America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Circulating Tumor Cells Market

  • 27.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Circulating Tumor Cells Market

  • 28.1. Middle East Circulating Tumor Cells Market Overview
  • 28.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Circulating Tumor Cells Market

  • 29.1. Africa Circulating Tumor Cells Market Overview
  • 29.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

  • 30.1. Circulating Tumor Cells Market Competitive Landscape
  • 30.2. Circulating Tumor Cells Market Company Profiles
    • 30.2.1. Precision Medicine Group LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Circulating Tumor Cells Market Other Major And Innovative Companies

  • 31.1. Ikonisys Inc.
  • 31.2. Qiagen N.V.
  • 31.3. ScreenCell SAS
  • 31.4. STEMCELL Technologies Inc.
  • 31.5. Sysmex Corporation
  • 31.6. Aviva Biosciences Corporation
  • 31.7. LungLife AI Inc.
  • 31.8. Miltenyi Biotec GmbH
  • 31.9. Menarini Silicon Biosystems S.p.A.
  • 31.10. Canopus Bioscience Ltd.
  • 31.11. IVDiagnostics Inc.
  • 31.12. BioFluidica Inc.
  • 31.13. Biolidics Limited
  • 31.14. Rarecells Diagnostics SAS
  • 31.15. LineaRx Inc.

32. Global Circulating Tumor Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

34. Recent Developments In The Circulating Tumor Cells Market

35. Circulating Tumor Cells Market High Potential Countries, Segments and Strategies

  • 35.1 Circulating Tumor Cells Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Circulating Tumor Cells Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Circulating Tumor Cells Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer